The economic fallout of Ozempic—and how it may impact docs

GLP-1 receptor agonists, such as Ozempic, have become wildly popular due to their weight-loss effects.

The emergence of these drugs has raised concerns among food and snack makers that their bottom lines might be affected if enough people start taking them.

It will take some time to see whether GLP-1 use will have a meaningful impact on company profits for the snack and food industry, but it’s not the only one who may experience an economic downturn—experts believe the healthcare industry will also be affected.